Clinical Collaboration with Merck to Evaluate Combination of ImmunoPulse® IL-12 and KEYTRUDA® (pembrolizumab) for Metastatic Melanoma They not just talking about it happening right now. Go to Clinical.gov for latest updates. ONCO